Pulmonx stock.

Jul 20, 2023 · Glendon E. French, III has not been actively trading shares of Pulmonx within the last three months. Most recently, Glendon E. French III sold 6,527 shares of the business's stock in a transaction on Friday, September 1st. The shares were sold at an average price of $10.01, for a transaction totalling $65,335.27. REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year of 2022 ended December 31, 2022.Oct 30, 2023 · Pulmonx Corporation is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. ... My Life My Lungs; Legal Name Pulmonx Corporation. Stock Symbol NASDAQ:LUNG; Company Type For Profit. Contact Email [email protected]; Phone Number 650-364-0400.Stock split history for Pulmonx since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Compare LUNG With Other Stocks Pulmonx Annual Stock Splits; Pulmonx Quarterly Stock Splits; Sector Industry

Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 7.32% and 11.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Nov 4, 2022 · Key Points. Pulmonx reported its Q3 results on Thursday, but its stock is falling primarily because of the company's planned securities offering. The company intends to sell up to $200 million of ... Pulmonx to Participate at Upcoming Investor Conferences. REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally ...

Company profile page for Pulmonx Corp including stock price, company news, press releases, executives, board members, and contact information.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...In the last ninety days, Geoffrey Beran Rose has sold $22,436.80 in shares of Pulmonx stock. Most recently, Geoffrey Beran Rose sold 1,184 shares of the business's stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $10.60, for a transaction totalling $12,550.40.Nov 3, 2022 · Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 5% and 9.42%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock? Pulmonx Corp Price to Earning is currently at 0.00 X. Price to Earnings ratio is typically used for current valuation of Pulmonx Corp and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when Pulmonx Corp's profitability falls, it is likely that earnings will also go down as well.

The latest price target for . Pulmonx (NASDAQ: LUNG) was reported by Piper Sandler on October 31, 2023.The analyst firm set a price target for $13.00 expecting LUNG to rise to within 12 months (a ...

Nov 21, 2023 · Pulmonx Stock Performance. Shares of Pulmonx stock opened at $10.85 on Tuesday. The firm has a market capitalization of $415.64 million, a P/E ratio of -6.70 and a beta of 0.48. Pulmonx Co. has a ...

Historical daily share price chart and data for Pulmonx since 2020 adjusted for splits and dividends. The latest closing stock price for Pulmonx as of November 17, 2023 is 10.85.. The all-time high Pulmonx stock closing price was 69.02 on December 31, 2020.; The Pulmonx 52-week high stock price is 14.28, which is 31.6% above the current share …Pulmonx Corporation (NASDAQ:LUNG) Released Earnings Last Week And Analysts Lifted Their Price Target To US$60.14. (Simply Wall St.) Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States ...Jeff Bezos Buys His Florida Neighbor’s Mansion for $79 Million. Company profile page for Pulmonx Corp including stock price, company news, press releases, executives, board members, and contact ... Short interest for Pulmonx gives investors a sense of the degree to which investors are betting on the decline of Pulmonx's stock. Short interest data is updated every two weeks.Positive. Nikkei 225. 31,650.96. -1.97%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Pulmonx Corp (LUNG.OQ) real-time stock quotes, news, price and financial information from ...

Get the latest Pulmonx Corp (LUNG) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Nov 8, 2023 · Verdict: Pulmonx Corporation lost a $1.59 a share on just over $53.6 million of revenue in FY2022. The current analyst firm consensus has losses increasing to $1.71 a share in FY2023 even as sales ... Pulmonx Corp stock price live 9.45, this page displays NASDAQ LUNG stock exchange data. View the LUNG premarket stock price ahead of the market session or assess the after hours quote.Pulmonx Corporation (LUNG.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Pulmonx Corporation | Nasdaq: LUNG | Nasdaq Company profile page for Pulmonx Corp including stock price, company news, press releases, executives, board members, and contact information.

Pulmonx Co. (NASDAQ:LUNG – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat.com reports. One analyst has ...Equities. Stock Pulmonx Corporation - Nasdaq. Pulmonx Corporation (LUNG.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock …

Pulmonx Stock Up 0.1 %. Shares of NASDAQ LUNG opened at $10.85 on Friday. Pulmonx Co. has a 12-month low of $5.15 and a 12-month high of $14.27. The firm’s 50-day simple moving average is $9.59 ...Oct 23, 2023 · Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 0001950047-23-004593.pdf. 0001950047-23-004593.rtf. 0001950047-23-004593.xls. View HTML. Oct 19, 2023. 3. Initial filing by director officer or owner of more than ten percent. When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Pulmonx Corporation (Nasdaq: LUNG) (' Pulmonx '), a global leader in minimally invasive treatments for severe lung disease, announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the Zephyr Endobronchial Valve for treating severe COPD/emphysema patients following a positive …First Quarter 2023 Financial Results. Total worldwide revenue in the first quarter of 2023 was $14.5 million, a 35% increase from $10.8 million in the first quarter of …The latest Roche stock prices, stock quotes, news, and RHHVF history to help you invest and trade smarter.

The U.S. market, in particular, has been a major contributor to Pulmonx’s growth, with $11.8 million in sales in the third quarter, representing a substantial 41% year-over-year growth (Q3 2023).

The increase in operating expenses was primarily attributable to investments in commercial activity and an increase in non-cash stock-based compensation. Net loss in the fourth quarter of 2022 was $14.3 million, or $0.38 per share, compared to a net loss of $13.0 million, or $0.35 per share, for the same period in 2021.

On November 1, 2023, Pulmonx Corp’s stock, with the ticker symbol LUNG, showed promising performance based on the information provided by CNN Money. The 12-month price forecasts from six analysts indicated a median target of $15.00, with a high estimate of $18.00 and a low estimate of $12.00.Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 0001950047-23-004593.pdf. 0001950047-23-004593.rtf. 0001950047-23-004593.xls. View HTML. Oct 19, 2023. 3. Initial filing by director officer or owner of more than ten percent.Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.Find the latest Pulmonx Corporation (LUNG) stock quote, history, news and other vital information to help you with your stock trading and investing.Pulmonx Corp [ LUNG] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: 10% Owner: X: Officer (give title below) ... Common Stock: 11/22/2023: S (1) 1,184: D $ 10.6: 249,469: D: Table II - Derivative Securities Acquired, Disposed of, or Beneficially OwnedPulmonx Corp · PLAYSTUDIOS Inc - Ordinary Shares - Class A · PLAYSTUDIOS Inc - Warrants (17/06/2026) · ProSomnus Inc · Pacer Funds Trust - Pacer BlueStar ...REDWOOD CITY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease ...Mar 10, 2023 · Pulmonx Corp’s Stock Price as of Market Close. As of March 10, 2023, 4:00 PM CST, Pulmonx Corp’s stock price was $10.74. Pulmonx Corp is down 5.79% from its previous closing price of $11.40. During the last market session, Pulmonx Corp’s stock traded between $11.23 and $11.93. Currently, there are 37.38 million shares of Pulmonx Corp ... otherwise, references in this Annual Report on Form 10-K to “Pulmonx” the “Company,” “we,” “us,” and “our” refer to Pulmonx Corporation. Risk Factors Summary Below is a summary of the principal factors that make an investment in our common stock speculative or risky. Importantly, this summary does notJeff Bezos Buys His Florida Neighbor’s Mansion for $79 Million. Company profile page for Pulmonx Corp including stock price, company news, press releases, executives, board members, and contact ...

Oct 30, 2023 · Pulmonx Corporation is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. The latest price target for . Pulmonx (NASDAQ: LUNG) was reported by Piper Sandler on October 31, 2023.The analyst firm set a price target for $13.00 expecting LUNG to rise to within 12 months (a ... Pulmonx also continues to expect total operating expenses for the full year 2023 to fall within the range of $112 million to $114 million, inclusive of approximately $22 million of non-cash stock ...What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...Instagram:https://instagram. pubccan you short on webullhigh yield brokerage accountswhat bank do rich people use Complete Pulmonx Corp. stock information by Barron's. View real-time LUNG stock price and news, along with industry-best analysis. crypto app with debit cardbest 529 interest rates Sep 24, 2020 · Quick Take. Pulmonx (NASDAQ:LUNG) has filed to raise $100 million from the sale of its common stock in an IPO, according to an amended registration statement.The company has developed a minimally ... The U.S. market, in particular, has been a major contributor to Pulmonx’s growth, with $11.8 million in sales in the third quarter, representing a substantial 41% year-over-year growth (Q3 2023). options analysis software Pulmonx Corp stock price live 9.45, this page displays NASDAQ LUNG stock exchange data. View the LUNG premarket stock price ahead of the market session or assess the after hours quote.The stock closed Thursday at $39.31 and rose as high as $47.80 on Friday. ... This is Pulmonx's second attempt this year at going public after shelving an earlier plan to raise up to $86 million ...